A detailed history of Ninety One Uk LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Ninety One Uk LTD holds 309,132 shares of LLY stock, worth $246 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
309,132
Previous 25,396 1117.25%
Holding current value
$246 Million
Previous $23 Million 1091.11%
% of portfolio
0.76%
Previous 0.06%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $219 Million - $272 Million
283,736 Added 1117.25%
309,132 $274 Million
Q1 2024

Apr 25, 2024

BUY
$592.2 - $792.28 $15 Million - $20.1 Million
25,396 New
25,396 $19.8 Million
Q3 2023

Oct 10, 2023

SELL
$434.7 - $599.3 $5 Million - $6.89 Million
-11,503 Reduced 33.46%
22,878 $12.3 Million
Q2 2023

Jul 19, 2023

SELL
$350.74 - $468.98 $6 Million - $8.02 Million
-17,101 Reduced 33.22%
34,381 $16.1 Million
Q1 2023

Apr 28, 2023

BUY
$310.63 - $364.82 $105,614 - $124,038
340 Added 0.66%
51,482 $17.7 Million
Q4 2022

Feb 07, 2023

SELL
$321.55 - $374.67 $3.11 Million - $3.62 Million
-9,664 Reduced 15.89%
51,142 $18.7 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $18 Million - $20.5 Million
60,806 New
60,806 $19.7 Million
Q4 2020

Feb 05, 2021

SELL
$130.46 - $172.63 $10,045 - $13,292
-77 Closed
0 $0
Q2 2020

Sep 04, 2020

SELL
$136.42 - $164.18 $5.12 Million - $6.16 Million
-37,516 Reduced 99.8%
77 $13,000
Q4 2019

Feb 07, 2020

SELL
$106.92 - $132.43 $142 Million - $175 Million
-1,324,282 Reduced 97.24%
37,593 $4.94 Million
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $1.7 Million - $1.85 Million
15,908 Added 1.18%
1,361,875 $152 Million
Q2 2019

Jul 30, 2019

SELL
$110.79 - $129.32 $54.9 Million - $64 Million
-495,208 Reduced 26.9%
1,345,967 $149 Million
Q1 2019

Apr 24, 2019

SELL
$111.31 - $131.02 $14.2 Million - $16.7 Million
-127,430 Reduced 6.47%
1,841,175 $239 Million
Q4 2018

Feb 08, 2019

SELL
$105.9 - $118.64 $76 Million - $85.1 Million
-717,564 Reduced 26.71%
1,968,605 $228 Million
Q3 2018

Nov 13, 2018

BUY
$85.86 - $107.31 $13.6 Million - $16.9 Million
157,890 Added 6.24%
2,686,169 $288 Million
Q2 2018

Aug 10, 2018

BUY
$75.7 - $86.88 $63.5 Million - $72.8 Million
838,271 Added 49.6%
2,528,279 $216 Million
Q1 2018

May 14, 2018

SELL
$74.21 - $87.6 $18.3 Million - $21.6 Million
-246,646 Reduced 12.74%
1,690,008 $131 Million
Q4 2017

Feb 13, 2018

BUY
$81.94 - $87.89 $159 Million - $170 Million
1,936,654
1,936,654 $164 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ninety One Uk LTD Portfolio

Follow Ninety One Uk LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ninety One Uk LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ninety One Uk LTD with notifications on news.